Legend Biotech Corporation
LEGN
$19.67
-$0.25-1.23%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 161.14% | -76.21% | 22.36% | 68.35% | -24.16% |
| Total Depreciation and Amortization | -25.00% | 30.35% | 103.57% | 1.36% | 13.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.72% | -23.48% | 145.16% | -89.20% | 115.23% |
| Change in Net Operating Assets | -33.33% | -141.93% | -165.93% | 230.04% | 50.95% |
| Cash from Operations | 75.44% | -597.26% | -142.38% | 318.19% | 87.26% |
| Capital Expenditure | 0.00% | 39.36% | -147.13% | 45.60% | -360.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 29.91% | -124.66% | 4,440.19% | 90.41% | -160.44% |
| Cash from Investing | 28.57% | -126.31% | 3,292.27% | 87.91% | -164.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3,353.85% | -35.70% | -59.14% | 49.83% | -50.00% |
| Issuance of Common Stock | 212,500.00% | -67.85% | -75.55% | 324.00% | -78.57% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 14,075.00% | -85.47% | -196.57% | 174.44% | -250.00% |
| Foreign Exchange rate Adjustments | 75.00% | 53.45% | -190.87% | -35.52% | 214.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 110.37% | -141.01% | 4,962.61% | 107.02% | -213.03% |